-
POPULATION PHARMACOKINETIC MODELING OF A NOVEL ONCE-DAILY LITHIUM CARBONATE EXTENDED RELEASE (XR) BI-LAYER MATRIX FORMULATION TO SUPPORT FORMULATION SWITCHING AND PEDIATRIC DOSING
Mar 18, 2026, 21:38 PM -
BEYOND THE SINGLE QALY: CHALLENGES IN APPLYING NON-HALY OUTCOMES IN ECONOMIC EVALUATIONS
Mar 18, 2026, 21:38 PM -
SURVEY OF ATTITUDES TOWARDS HPV VACCINATION AMONG YOUNG PEOPLE
Mar 18, 2026, 21:38 PM -
EVALUATION OF MACHINE LEARNING-ASSISTED DATA EXTRACTION FOR SUPPORTING SYSTEMATIC REVIEWS.VA CASE STUDY OF A REVIEW IN MOVEMENT DISORDERS
Mar 18, 2026, 21:38 PM -
IMPACT OF PULMONARY ARTERIAL HYPERTENSION ON HEART-LUNG TRANSPLANTATION OUTCOMES AND COSTS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF SGLT2 INHIBITORS VERSUS RAAS BLOCKERS IN SLOWING CKD PROGRESSION AMONG PATIENTS WITH DIABETIC NEPHROPATHY: INSIGHTS FROM REAL WORLD DATA
Mar 18, 2026, 21:38 PM -
TARGET TRIAL EMULATION (TTE) INFORMED BY CLINICAL TRIAL DATA: ADJUVANT NIVOLUMAB VS OBSERVATION IN PATIENTS WITH RESECTABLE NON-SMALL CELL LUNG CANCER (RNSCLC) AFTER NEOADJUVANT NIVOLUMAB PLUS CHEMOTHERAPY AND SURGERY
Mar 18, 2026, 21:38 PM -
EVALUATING THE PATIENT BURDEN ASSOCIATED WITH DELAYED REIMBURSEMENT: A CASE STUDY OF PEMBROLIZUMAB IN THE TREATMENT OF ENDOMETRIAL CANCER IN CANADA
Mar 18, 2026, 21:38 PM -
ENHANCING REAL-WORLD DATA (RWD) QUALITY: IMPLEMENTATION OF REGULATORY DATA QUALITY FRAMEWORK WITHIN A LARGE US ONCOLOGY ELECTRONIC HEALTH RECORD (EHR)-DERIVED DATABASE
Mar 18, 2026, 21:38 PM -
FIRST-LINE CDK4/6 INHIBITOR USE IN METASTATIC BREAST CANCER: REAL-WORLD DATA FROM A RETROSPECTIVE US COHORT STUDY
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION IN LONG-TERM CARE RESIDENTS WITH AGITATION ASSOCIATED WITH DEMENTIA DUE TO ALZHEIMER’S DISEASE TREATED WITH BREXPIPRAZOLE
Mar 18, 2026, 21:38 PM -
COMPARATIVE MEASUREMENT OF ESKETAMINE RESPONSE IN TREATMENT-RESISTANT DEPRESSION USING PHQ-9 AND DSM-5 CRITERIA
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT ANALYSIS OF DONISLECEL FOR ELIGIBLE ADULTS WITH TYPE I DIABETES IN THE UNITED STATES: AN ANALYSIS FROM A PAYER PERSPECTIVE
Mar 18, 2026, 21:38 PM -
CORTICOSTEROID AND BIOLOGIC USE IN A REAL-WORLD POPULATION WITH GENERALIZED MYASTHENIA GRAVIS IN THE UNITED STATES AND GERMANY
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS, OUTCOMES, AND RESOURCE UTILIZATION IN US ADULTS WITH NF1-PN
Mar 18, 2026, 21:38 PM -
VALIDATION OF A NEW CLINICAL OUTCOME ASSESSMENT: THE VACCINATION EXPERIENCE QUESTIONNAIRE (VEQ)
Mar 18, 2026, 21:38 PM -
THE FEASIBILITY OF MEASURING BTKI MEDICATION ADHERENCE IN THE TREATMENT OF CLL/SLL USING AN ELECTRONIC PATIENT-REPORTED OUTCOMES (EPRO) PLATFORM
Mar 18, 2026, 21:38 PM -
PARENTAL BURNOUT AMONG MOTHERS: THE ROLE OF COPING STYLES AND PSYCHOLOGICAL FACTORS
Mar 18, 2026, 21:38 PM -
GENERATIVE AI-ENABLED OBJECTION HANDLING TO SUPPORT PAYER ENGAGEMENT IN ADJUVANT MELANOMA THERAPY
Mar 18, 2026, 21:38 PM -
VALUE-BASED PURCHASING ARRANGEMENTS IN MEDICAID: A TARGETED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM
